- Home
- PRQR vs MDV Comparison
PRQR vs MDV Comparison
Compare PRQR & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRQR | MDV |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | Netherlands | United States |
| Employees | N/A | 12 |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.5M | 159.4M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRQR | MDV |
|---|---|---|
| Price | $1.48 | $14.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $6.80 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 291.4K | 57.0K |
| Earning Date | 03-12-2026 | 03-25-2026 |
| Dividend Yield | N/A | ★ 8.50% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.88 | $0.33 |
| Revenue Next Year | N/A | $6.43 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.08 | $13.62 |
| 52 Week High | $3.10 | $17.15 |
Technical Indicators
Market Signals| Indicator | PRQR | MDV |
|---|---|---|
| Relative Strength Index (RSI) | 43.57 | 44.92 |
| Support Level | $1.33 | $14.08 |
| Resistance Level | $1.58 | $14.94 |
| Average True Range (ATR) | 0.12 | 0.40 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 26.00 | 46.22 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
About MDV Modiv Industrial Inc. Class C
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.